Better Therapeutics, Inc. Banner Image

Better Therapeutics, Inc.

  • Ticker BTTX
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Better Therapeutics, Inc. Logo Image
  • 51-200 Employees
  • Based in San Francisco, California
Better Therapeutics is a prescription digital therapeutics company developing a novel form of cognitive behavioral therapy to address underlying factors that sustain or worsen cardiometabolic diseases. The Company has developed a proprietary platform for the development of FDA-regulated, software-based solutions and in July 2023 received FDA authorization for AspyreRx™ to treat adults withMore type 2 diabetes. The CBT delivered by Better Therapeutics’ PDT is designed to enable changes in neural pathways of the brain so lasting changes in behavior become possible. Addressing the underlying causes of these diseases has the potential to dramatically improve patient health while lowering healthcare costs. Better Therapeutics’ clinically validated mobile applications are intended to be prescribed by physicians and reimbursed like traditional medicines.
Better Therapeutics, Inc.

Most Recent Annual Report

Better Therapeutics, Inc.
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

Better Therapeutics, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!